Rafferty Asset Management
INBX icon

Rafferty Asset Management’s Inhibrx INBX Stock Holding History

Rafferty Asset Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
15,761
+7,179
+84% +$533K ﹤0.01% 750
2025
Q4 		$678K Buy
+8,582
New +$585K ﹤0.01% 860

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rafferty Asset Management's INBX Position: Q1 2026 in Review

Rafferty Asset Management increased its Inhibrx (INBX) stake by 84% in Q1 2026, buying an estimated $533K and bringing the position to 15,761 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #750.

Rafferty Asset Management first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Rafferty Asset Management held 15,761 shares of Inhibrx worth $1.06M as of Q1 2026.
  • Rafferty Asset Management bought 7,179 Inhibrx shares in Q1 2026, an estimated $533K.
  • Inhibrx made up ﹤0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #750 holding.
  • Rafferty Asset Management first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.